Stockscreener 앱 받기
0.72
3.00%
0.021
시간 외 거래:
.72
전일 마감가:
$0.699
열려 있는:
$0.7031
하루 거래량:
18,467
Relative Volume:
0.39
시가총액:
$19.78M
수익:
$1.13M
순이익/손실:
$-20.74M
주가수익비율:
-0.383
EPS:
-1.88
순현금흐름:
$-18.37M
1주 성능:
+1.41%
1개월 성능:
-6.98%
6개월 성능:
-48.57%
1년 성능:
-48.57%
1일 변동 폭
$0.6501
$0.729
1주일 범위
$0.6147
$0.74
52주 변동 폭
$0.5946
$2.115
Cyclo Therapeutics Inc Stock (CYTH) Company Profile
명칭
Cyclo Therapeutics Inc
전화
386-418-8060
주소
6714 NW 16TH STREET, SUITE B, GAINESVILLE
CYTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| CYTH | 0.72 | 19.78M | 1.13M | -20.74M | -18.37M | -1.88 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Cyclo Therapeutics Inc 주식(CYTH)의 최신 뉴스
TeleChoice International’s Path to Exiting SGX Watch-list - MSN
Cyclo Therapeutics Inc (CYTH) Quarterly 10-Q Report - Quartzy
Cyclo Therapeutics Completes Phase 3 Trial Enrollment, Plans 2025 NDA Filing Amid Merger | CYTH Stock News - StockTitan
Cyclo Therapeutics, Inc. (CYTH) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Well Health Stock: Buy, Sell, or Hold? - MSN
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com
Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com
Niemann-Pick Disease Type C Pipeline 2024: Clinical Trials - openPR
Astrazeneca: How a fraud investigation crashed a FTSE 100 giant - MSN
Rafael Holdings Inc. Class B (RFL) Annual 10-K Report - Quartzy
Analysts Set Cognition Therapeutics, Inc. (NASDAQ:CGTX) PT at $8.00 - Defense World
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - ForexTV.com
Rafael Holdings Reports $34.4M Loss, Inks Merger Deal with Cyclo Therapeutics | RFL Stock News - StockTitan
Sofi Technologies Inc (SOFI-Q) QuotePress Release - The Globe and Mail
Pacira BioSciences Reports Third Quarter 2024 Financial Results - The Manila Times
TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail
Pilgrim's Pride (PPC-Q) QuotePress Release - The Globe and Mail
Kuehn Law Encourages CDE, SMC, COFS, and RFL Investors to Contac - GuruFocus.com
Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals - BioCentury
Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
What Q3 investment banking trends reveal about the economy - Fortune
Will Cyclo Therapeutics Get A Boost From NPC-1 Trial Data? - RTTNews
Pacira BioSciences Appoints Shawn Cross As Chief Financial Officer - citybiz
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer - The Manila Times
Niemann Pick Disease Drug Type C Treatment Market Industry - openPR
Deal Watch: Lilly Turns To Oblique For Antibody Discovery - Scrip
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
Alkermes (ALKS) Stock Surges Amid Strong Financial Results - GuruFocus.com
Maxim Group Downgrades Cyclo Therapeutics (CYTH) - MSN
Cyclo Therapeutics faces Nasdaq delisting over non-compliance - Investing.com
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Position Increased by Handelsbanken Fonder AB - Defense World
Cyclo Therapeutics faces Nasdaq delisting over non-compliance By Investing.com - Investing.com UK
Cyclo Therapeutics secures $3 million in funding from Rafael Holdings By Investing.com - Investing.com South Africa
Cyclo Therapeutics secures $3 million in funding from Rafael Holdings - Investing.com India
Kuehn Law Encourages CDE, SMC, COFS, and RFL Investors to Contact Law Firm - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, SMC, COFS, RFL on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of RFL, PORT and MNTX - AccessWire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, COFS, RFL on Behalf of Shareholders - Lelezard.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTX and RFL on Behalf of Shareholders - AccessWire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMAR, MNTX, RFL on Behalf of Shareholders - The Malaysian Reserve
Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail
Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, GATO, RFL on Behalf of Shareholders - The Malaysian Reserve
Take your (Niemann-) Pick: Intrabio’s Aqneursa wins FDA nod - BioWorld Online
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) & Cyclo Therapeutics (NASDAQ:CYTH) - Defense World
Cyclo-oxygenase 2 Inhibitors Clinical Trial Pipeline - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COFS, ARC, NBY, RFL on Behalf of Shareholders - GlobeNewswire
Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm - The Malaysian Reserve
Cyclo Therapeutics Inc (CYTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
0.15%
자본화:
|
볼륨(24시간):